Related references
Note: Only part of the references are listed.Clinical performance of an antibody-free assay for plasma Aβ42/Aβ40 to detect early alterations of Alzheimer's disease in individuals with subjective cognitive decline
Maria Pascual-Lucas et al.
ALZHEIMERS RESEARCH & THERAPY (2023)
Plasma p-tau231, p-tau181, PET Biomarkers, and Cognitive Change in Older Adults
Pierre-Francois Meyer et al.
ANNALS OF NEUROLOGY (2022)
Amyloid Positive Hydrocephalus: A Hydrocephalic Variant of Alzheimer's Disease?
Hyemin Jang et al.
JOURNAL OF ALZHEIMERS DISEASE (2022)
Validation of Plasma Amyloid-β 42/40 for Detecting Alzheimer Disease Amyloid Plaques
Yan Li et al.
NEUROLOGY (2022)
The accuracy and robustness of plasma biomarker models for amyloid PET positivity
Andrea L. Benedet et al.
ALZHEIMERS RESEARCH & THERAPY (2022)
Aβ42/Aβ40 ratio in plasma predicts amyloid‐PET status in amnestic‐MCI patients
María Pascual‐Lucas et al.
Alzheimers & Dementia (2021)
Longitudinal pathways of cerebrospinal fluid and positron emission tomography biomarkers of amyloid-β positivity
Arianna Sala et al.
MOLECULAR PSYCHIATRY (2021)
Performance of the plasma Aβ42/Aβ40 ratio, measured with a novel HPLC-MS/MS method, as a biomarker of amyloid PET status in a DPUK-KOREAN cohort
Hyemin Jang et al.
ALZHEIMERS RESEARCH & THERAPY (2021)
A blood-based diagnostic test incorporating plasma Aβ42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: findings from a multi cohort validity analysis
Tim West et al.
MOLECULAR NEURODEGENERATION (2021)
Head-to-Head Comparison of 8 Plasma Amyloid-beta 42/40 Assays in Alzheimer Disease
Shorena Janelidze et al.
JAMA NEUROLOGY (2021)
A new Centiloid method for 18F-florbetaben and 18F-flutemetamol PET without conversion to PiB
Soo Hyun Cho et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Comparison of Diagnostic Performances Between Cerebrospinal Fluid Biomarkers and Amyloid PET in a Clinical Setting
Na-Yeon Jung et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Total Aβ42/Aβ40 ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosis
James D. Doecke et al.
NEUROLOGY (2020)
Appropriate reference region selection of 18F-florbetaben and 18F-flutemetamol beta-amyloid PET expressed in Centiloid
Soo Hyun Cho et al.
SCIENTIFIC REPORTS (2020)
Cerebrospinal Fluid Biomarkers for the Diagnosis and Classification of Alzheimer's Disease Spectrum
Jongmin Lee et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2020)
Longitudinal evaluation of the natural history of amyloid-β in plasma and brain
Samantha C. Burnham et al.
BRAIN COMMUNICATIONS (2020)
Clinical significance of amyloid positivity in patients with probable cerebral amyloid angiopathy markers
Hyemin Jang et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis
Suzanne E. Schindler et al.
NEUROLOGY (2019)
CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts
Oskar Hansson et al.
ALZHEIMERS & DEMENTIA (2018)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Role of Blood-Brain Barrier in Alzheimer's Disease
Zhiyou Cai et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
High performance plasma amyloid-β biomarkers for Alzheimer's disease
Akinori Nakamura et al.
NATURE (2018)
Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
Melanie D. Sweeney et al.
NATURE REVIEWS NEUROLOGY (2018)
Plasma Amyloid as Prescreener for the Earliest Alzheimer Pathological Changes
Inge M. W. Verberk et al.
ANNALS OF NEUROLOGY (2018)
Blood-brain barrier breakdown, neuroinflammation, and cognitive decline in older adults
Gene L. Bowman et al.
ALZHEIMERS & DEMENTIA (2018)
A Nomogram for Predicting Amyloid PET Positivity in Amnestic Mild Cognitive Impairment
Si Eun Kim et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Cerebrospinal Fluid A beta(42/40) Corresponds Better than A beta(42) to Amyloid PET in Alzheimer's Disease
Piotr Lewczuk et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Concordance Between Different Amyloid Immunoassays and Visual Amyloid Positron Emission Tomographic Assessment
Shorena Janelidze et al.
JAMA NEUROLOGY (2017)
Cerebrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography
Sebastian Palmqvist et al.
BRAIN (2016)
CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease
Shorena Janelidze et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET
William E. Klunk et al.
ALZHEIMERS & DEMENTIA (2015)
A Consensus in Korea Regarding a Protocol to Reduce Preanalytical Sources of Variability in the Measurement of the Cerebrospinal Fluid Biomarkers of Alzheimer's Disease
Sun Ah Park et al.
JOURNAL OF CLINICAL NEUROLOGY (2015)
Amyloid biomarkers in Alzheimer's disease
Kai Blennow et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Impaired vascular-mediated clearance of brain amyloid beta in Alzheimer's disease: the role, regulation and restoration of LRP1
Anita Ramanathan et al.
FRONTIERS IN AGING NEUROSCIENCE (2015)
Amyloid-β Efflux from the Central Nervous System into the Plasma
Kaleigh Filisa Roberts et al.
ANNALS OF NEUROLOGY (2014)
Concordance Between Cerebrospinal Fluid Biomarkers and [C-11] PIB PET in a Memory Clinic Cohort
Marissa Zwan et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2014)
Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42 A Cross-Validation Study Against Amyloid Positron Emission Tomography
Sebastian Palmqvist et al.
JAMA NEUROLOGY (2014)
Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association
Keith A. Johnson et al.
ALZHEIMERS & DEMENTIA (2013)
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study (vol 11, pg 669, 2012)
C. M. Clark et al.
LANCET NEUROLOGY (2012)
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study
Christopher M. Clark et al.
LANCET NEUROLOGY (2012)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
Seoul Neuropsychological Screening Battery-Dementia Version (SNSB-D): A Useful Tool for Assessing and Monitoring Cognitive Impairments in Dementia Patients
Hyun-Jung Ahn et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2010)
Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain
Tero Tapiola et al.
ARCHIVES OF NEUROLOGY (2009)
Apolipoprotein E, amyloid-beta, and blood-brain barrier permeability in Alzheimer disease
John E. Donahue et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia
Sebastiaan Engelborghs et al.
NEUROBIOLOGY OF AGING (2008)
Imaging of amyloid burden and distribution in cerebral amyloid angiopathy
Keith A. Johnson et al.
ANNALS OF NEUROLOGY (2007)
Blood-brain barrier impairment in Alzheimer disease - Stability and functional significance
G. L. Bowman et al.
NEUROLOGY (2007)
Amyloid β-peptide1-42 alters tight junction protein distribution and expression in brain microvessel endothelial cells
Sonia Marco et al.
NEUROSCIENCE LETTERS (2006)
Clearing amyloid through the blood-brain barrier
BV Zlokovic
JOURNAL OF NEUROCHEMISTRY (2004)
CSF Aβ 42 levels correlate with amyloid-neuropathology in a population-based autopsy study
D Strozyk et al.
NEUROLOGY (2003)
Substitution at codon 22 reduces clearance of Alzheimer's amyloid-β peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood
OR Monro et al.
NEUROBIOLOGY OF AGING (2002)
Impairment of the blood-nerve and blood-brain barriers in apolipoprotein E knockout mice
SM Fullerton et al.
EXPERIMENTAL NEUROLOGY (2001)
Share Paper
